| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3826746 | Progrès en Urologie | 2013 | 7 Pages |
Abstract
The URS-SL was a first-line treatment validated regardless of size and number of kidney stones, when ESWL and PCNL were contraindicated or when their predictable results were poor (hard stones/morbid obesity/lower pole stones) or when stone access is difficult (intradiverticular). It was also the treatment of choice after the failure of a first treatment (ESWL/PCNL).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
V. Estrade, K. Bensalah, J.-P. Bringer, E. Chabannes, X. Carpentier, P. Conort, E. Denis, B. Doré, J.R. Gautier, H. Hadjadj, J. Hubet, A. Hoznek, E. Lechevallier, P. Meria, P. Mozer, C. Saussine, L. Yonneau, O. Traxer,